Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
TSRO > SEC Filings for TSRO > Form 8-K on 24-Dec-2013All Recent SEC Filings

Show all filings for TESARO, INC.

Form 8-K for TESARO, INC.


24-Dec-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On December 23, 2013, TESARO, Inc. issued a press release announcing top-line results from two phase 3 clinical trials of rolapitant, an investigational neurokinin-1 (NK-1) receptor antagonist in development for the prevention of chemotherapy-induced nausea and vomiting (CINV). A copy of the press release announcing these results is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description

99.1 TESARO, Inc. press release dated December 23, 2013


  Add TSRO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for TSRO - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.